blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2275430

EP2275430 - HEMIFUMARATE OF A PYRAZOLE DERIVATIVE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  22.03.2013
Database last updated on 19.07.2024
Most recent event   Tooltip17.07.2015Lapse of the patent in a contracting state
New state(s): HU		published on 19.08.2015  [2015/34]
Applicant(s)For all designated states
Kissei Pharmaceutical Co., Ltd.
19-48, Yoshino Matsumoto-shi
Nagano 399-8710 / JP
[2011/03]
Inventor(s)01 / TAKEUCHI, Hideki
c/o Joetsu Chemical Laboratories
Kissei Pharmaceutical Co. Ltd.
197-5, Kamiyoshi
Kubiki-ku
Joetsu-shi Niigata 942-0145 / JP
02 / TSURU, Eiji
c/o Joetsu Chemical Laboratories
Kissei Pharmaceutical Co. Ltd.
197-5, Kamiyoshi
Kubiki-ku
Joetsu-shi Niigata 942-0145 / JP
 [2012/20]
Former [2011/03]01 / TAKEUCHI, Hideki
c/o Joetsu Chemical Laboratories Kissei Pharmaceutical Co. Ltd. 197-5, Kamiyoshi Kubiki-ku
Joetsu-shi Niigata 942-0145 / JP
02 / TSURU, Eiji
c/o Joetsu Chemical Laboratories Kissei Pharmaceutical Co. Ltd. 197-5, Kamiyoshi Kubiki-ku
Joetsu-shi Niigata 942-0145 / JP
Representative(s)Hayes, Adrian Chetwynd
Boult Wade Tennant
Verulam Gardens
70 Gray's Inn Road
London WC1X 8BT / GB
[N/P]
Former [2012/20]Hayes, Adrian Chetwynd
Boult Wade Tennant Verulam Gardens 70 Gray's Inn Road
London WC1X 8BT / GB
Former [2011/03]Hayes, Adrian Chetwynd
Boult Wade Tennant Verulam Gardens 70 Gray's Inn Road
London WC1X 8BT / GB
Application number, filing date09733364.513.04.2009
[2011/03]
WO2009JP57439
Priority number, dateJP2008010658216.04.2008         Original published format: JP 2008106582
[2011/03]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2009128421
Date:22.10.2009
Language:JA
[2009/43]
Type: A1 Application with search report 
No.:EP2275430
Date:19.01.2011
Language:EN
[2011/03]
Type: B1 Patent specification 
No.:EP2275430
Date:16.05.2012
Language:EN
[2012/20]
Search report(s)International search report - published on:JP22.10.2009
(Supplementary) European search report - dispatched on:EP07.03.2011
ClassificationIPC:C07H17/02, A61K31/7056, A61P3/10
[2011/03]
CPC:
C07H17/02 (EP,US); A61P3/10 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2011/03]
TitleGerman:HEMIFUMARAT EINES PYRAZOLDERIVATS[2011/03]
English:HEMIFUMARATE OF A PYRAZOLE DERIVATIVE[2011/03]
French:HÉMIFUMARATE D UN DÉRIVÉ DE PYRAZOLE[2011/03]
Entry into regional phase12.10.2010Translation filed 
12.10.2010National basic fee paid 
12.10.2010Search fee paid 
12.10.2010Designation fee(s) paid 
12.10.2010Examination fee paid 
Examination procedure12.10.2010Examination requested  [2011/03]
23.09.2011Amendment by applicant (claims and/or description)
24.11.2011Communication of intention to grant the patent
21.03.2012Fee for grant paid
21.03.2012Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  24.11.2011
Opposition(s)19.02.2013No opposition filed within time limit [2013/17]
Fees paidRenewal fee
26.04.2011Renewal fee patent year 03
29.03.2012Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU13.04.2009
AT16.05.2012
BE16.05.2012
CY16.05.2012
CZ16.05.2012
DK16.05.2012
EE16.05.2012
FI16.05.2012
HR16.05.2012
LT16.05.2012
LV16.05.2012
MC16.05.2012
MK16.05.2012
MT16.05.2012
NL16.05.2012
PL16.05.2012
RO16.05.2012
SE16.05.2012
SI16.05.2012
SK16.05.2012
TR16.05.2012
BG16.08.2012
NO16.08.2012
GR17.08.2012
IS16.09.2012
PT17.09.2012
[2015/34]
Former [2015/32]AT16.05.2012
BE16.05.2012
CY16.05.2012
CZ16.05.2012
DK16.05.2012
EE16.05.2012
FI16.05.2012
HR16.05.2012
LT16.05.2012
LV16.05.2012
MC16.05.2012
MK16.05.2012
MT16.05.2012
NL16.05.2012
PL16.05.2012
RO16.05.2012
SE16.05.2012
SI16.05.2012
SK16.05.2012
TR16.05.2012
BG16.08.2012
NO16.08.2012
GR17.08.2012
IS16.09.2012
PT17.09.2012
Former [2015/13]AT16.05.2012
BE16.05.2012
CY16.05.2012
CZ16.05.2012
DK16.05.2012
EE16.05.2012
FI16.05.2012
HR16.05.2012
LT16.05.2012
LV16.05.2012
MC16.05.2012
MT16.05.2012
NL16.05.2012
PL16.05.2012
RO16.05.2012
SE16.05.2012
SI16.05.2012
SK16.05.2012
BG16.08.2012
NO16.08.2012
GR17.08.2012
IS16.09.2012
PT17.09.2012
Former [2014/01]AT16.05.2012
BE16.05.2012
CY16.05.2012
CZ16.05.2012
DK16.05.2012
EE16.05.2012
FI16.05.2012
HR16.05.2012
LT16.05.2012
LV16.05.2012
MC16.05.2012
NL16.05.2012
PL16.05.2012
RO16.05.2012
SE16.05.2012
SI16.05.2012
SK16.05.2012
BG16.08.2012
NO16.08.2012
GR17.08.2012
IS16.09.2012
PT17.09.2012
Former [2013/34]AT16.05.2012
BE16.05.2012
CY16.05.2012
CZ16.05.2012
DK16.05.2012
EE16.05.2012
FI16.05.2012
HR16.05.2012
LT16.05.2012
LV16.05.2012
NL16.05.2012
PL16.05.2012
RO16.05.2012
SE16.05.2012
SI16.05.2012
SK16.05.2012
BG16.08.2012
NO16.08.2012
GR17.08.2012
IS16.09.2012
PT17.09.2012
Former [2013/10]AT16.05.2012
BE16.05.2012
CY16.05.2012
CZ16.05.2012
DK16.05.2012
EE16.05.2012
FI16.05.2012
HR16.05.2012
LT16.05.2012
LV16.05.2012
NL16.05.2012
PL16.05.2012
RO16.05.2012
SE16.05.2012
SI16.05.2012
SK16.05.2012
NO16.08.2012
GR17.08.2012
IS16.09.2012
PT17.09.2012
Former [2013/09]AT16.05.2012
BE16.05.2012
CY16.05.2012
DK16.05.2012
EE16.05.2012
FI16.05.2012
HR16.05.2012
LT16.05.2012
LV16.05.2012
NL16.05.2012
PL16.05.2012
SE16.05.2012
SI16.05.2012
NO16.08.2012
GR17.08.2012
IS16.09.2012
PT17.09.2012
Former [2013/08]AT16.05.2012
BE16.05.2012
CY16.05.2012
DK16.05.2012
FI16.05.2012
HR16.05.2012
LT16.05.2012
LV16.05.2012
NL16.05.2012
PL16.05.2012
SE16.05.2012
SI16.05.2012
NO16.08.2012
GR17.08.2012
IS16.09.2012
PT17.09.2012
Former [2013/07]AT16.05.2012
BE16.05.2012
CY16.05.2012
FI16.05.2012
HR16.05.2012
LT16.05.2012
LV16.05.2012
PL16.05.2012
SE16.05.2012
SI16.05.2012
NO16.08.2012
GR17.08.2012
IS16.09.2012
PT17.09.2012
Former [2013/04]BE16.05.2012
CY16.05.2012
FI16.05.2012
HR16.05.2012
LT16.05.2012
LV16.05.2012
PL16.05.2012
SE16.05.2012
SI16.05.2012
NO16.08.2012
GR17.08.2012
IS16.09.2012
PT17.09.2012
Former [2013/01]CY16.05.2012
FI16.05.2012
HR16.05.2012
LT16.05.2012
LV16.05.2012
PL16.05.2012
SE16.05.2012
SI16.05.2012
NO16.08.2012
GR17.08.2012
IS16.09.2012
PT17.09.2012
Former [2012/51]CY16.05.2012
FI16.05.2012
HR16.05.2012
LT16.05.2012
LV16.05.2012
PL16.05.2012
SE16.05.2012
SI16.05.2012
NO16.08.2012
GR17.08.2012
IS16.09.2012
Former [2012/50]CY16.05.2012
FI16.05.2012
HR16.05.2012
LT16.05.2012
LV16.05.2012
PL16.05.2012
SE16.05.2012
NO16.08.2012
GR17.08.2012
IS16.09.2012
Former [2012/49]CY16.05.2012
FI16.05.2012
LT16.05.2012
PL16.05.2012
SE16.05.2012
NO16.08.2012
IS16.09.2012
Former [2012/48]FI16.05.2012
LT16.05.2012
SE16.05.2012
NO16.08.2012
Former [2012/47]LT16.05.2012
NO16.08.2012
Documents cited:Search   [ ] - No further relevant documents disclosed
International search[Y]WO0218403  (CHUGAI PHARMACEUTICAL CO LTD [JP], et al);
 [Y]JP2003517468  (WYETH);
 [Y]WO2004018491  (KISSEI PHARMACEUTICAL [JP], et al);
 [Y]JP2007516243  (SANOFI-AVENTIS DEUT GMBH);
 [Y]WO2007080170  (BOEHRINGER INGELHEIM INT [DE], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.